Cargando…
Infantile Colic Treated With Bifidobacterium longum CECT7894 and Pediococcus pentosaceus CECT8330: A Randomized, Double-Blind, Placebo-Controlled Trial
Background: Colic is a common condition in infants <4 months of age. Attempts to treat infantile colic with probiotics have shown variable efficacy and overall low evidence of success. In this work, we tested the hypothesis that oral administration of Bifidobacterium longum CECT7894 (KABP042) and...
Autores principales: | Chen, Ke, Liu, Changqi, Li, Hua, Lei, Yuehua, Zeng, Chenggui, Xu, Shuhong, Li, Jianqiu, Savino, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461252/ https://www.ncbi.nlm.nih.gov/pubmed/34568236 http://dx.doi.org/10.3389/fped.2021.635176 |
Ejemplares similares
-
Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice
por: Dong, Fang, et al.
Publicado: (2022) -
Bifidobacterium longum CECT 7894 Improves the Efficacy of Infliximab for DSS-Induced Colitis via Regulating the Gut Microbiota and Bile Acid Metabolism
por: Xiao, Fangfei, et al.
Publicado: (2022) -
Identification of a Peptide Produced by Bifidobacterium longum CECT 7210 with Antirotaviral Activity
por: Chenoll, Empar, et al.
Publicado: (2016) -
Bifidobacterium longum subsp. infantis CECT 7210 Reduces Inflammatory Cytokine Secretion in Caco-2 Cells Cultured in the Presence of Escherichia coli CECT 515
por: Álvarez-Mercado, Ana I., et al.
Publicado: (2022) -
Bifidobacterium longum CECT 7347 Modulates Immune Responses in a Gliadin-Induced Enteropathy Animal Model
por: Laparra, José Moisés, et al.
Publicado: (2012)